# 脳震盪市場

> 脳震盪市場調査報告書 情報 診断と治療（診断、治療）、エンドユーザー別（病院とクリニック、診断センターと支払者）、地域別（北米、ヨーロッパ、アジア太平洋、その他の地域） – 2035年までの市場予測

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.6%
- **2024:** $ 6.34 Billion
- **2025:** $ 6.69 Billion
- **2035:** $ 11.54 Billion
- **Key Players:** Abbott Laboratories (US), Medtronic (US), Boston Scientific (US), Stryker Corporation (US), Cortech Solutions (US), Zynex Medical (US), Neurotech Pharmaceuticals (US), Huntleigh Healthcare (GB), B. Braun Melsungen AG (DE)

**Report ID:** MRFR/Pharma/4269-CR · **Pages:** 145 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** September 18, 2026

**URL:** https://www.marketresearchfuture.com/reports/concussions-market-5724

---

## Market Summary

As per Market Research Future analysis, the Concussions Market Size was estimated at 6.336 USD Billion in 2024. The Concussions industry is projected to grow from 6.691 USD Billion in 2025 to 11.54 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.6% during the forecast period 2025 - 2035

## Market Drivers

### Advancements in Medical Technology

Technological innovations in medical devices and diagnostic tools are transforming the Concussions Market. The development of advanced imaging techniques, such as MRI and CT scans, has improved the accuracy of concussion diagnoses, enabling healthcare professionals to make informed decisions regarding treatment.
 
Furthermore, [wearable technology](https://www.marketresearchfuture.com/reports/wearable-technology-market-2336) that monitors head impacts is gaining traction, providing real-time data that can help prevent concussions. The market for these technologies is projected to grow, driven by the increasing demand for effective and efficient diagnostic solutions. As healthcare providers adopt these advancements, the overall quality of care for concussion patients is expected to improve, further propelling market growth.

### Rising Awareness of Concussion Risks

The increasing awareness surrounding the risks associated with concussions is a pivotal driver in the Concussions Market. Educational campaigns and advocacy from health organizations have heightened public consciousness about the long-term effects of concussions, particularly in contact sports. This awareness has led to a surge in demand for diagnostic tools and treatment options, as individuals seek to understand and mitigate the risks.
 
According to recent data, the prevalence of diagnosed concussions has risen significantly, indicating a growing recognition of the condition. As more individuals become informed about the potential consequences of concussions, the market is likely to expand, with a focus on innovative solutions for prevention and management.

### Increased Participation in Contact Sports

The rising participation rates in contact sports, particularly among youth, is a significant driver in the Concussions Market. As more children and adolescents engage in sports such as football, hockey, and rugby, the incidence of concussions is likely to increase. This trend has prompted schools and sports organizations to implement stricter safety protocols and concussion management programs.
 
Consequently, there is a growing demand for educational resources, training programs, and protective equipment designed to minimize the risk of concussions. The market is responding to this need by offering a variety of products aimed at enhancing player safety and promoting awareness of concussion-related issues.

### Regulatory Support for Concussion Management

Regulatory bodies are increasingly recognizing the importance of effective concussion management, which serves as a crucial driver in the Concussions Market. New guidelines and policies aimed at improving the safety of athletes have been established, mandating that organizations implement comprehensive concussion protocols.
 
This regulatory support not only enhances the safety of participants but also drives the demand for related products and services, including training programs for coaches and medical staff. As compliance with these regulations becomes essential, the market is likely to see growth in areas such as educational materials and concussion assessment tools, reflecting the commitment to athlete safety.

### Growing Investment in Research and Development

Investment in research and development within the Concussions Market is on the rise, driven by the need for innovative solutions to address the complexities of concussion management. Funding from both public and private sectors is being directed towards studies that explore the long-term effects of concussions and the efficacy of various treatment options.
 
This influx of capital is fostering the development of new therapies, diagnostic tools, and preventive measures. As research continues to unveil new insights into concussion management, the market is expected to expand, offering a wider array of products and services aimed at improving outcomes for individuals affected by concussions.

## Future Outlook

脳震盪市場は2025年から2035年までの5.6%のCAGRで成長すると予測されており、意識の高まり、先進的な診断技術、そして強化された治療オプションが推進要因です。

**New opportunities:**

- 遠隔の脳震盪評価のためのテレヘルスプラットフォームの開発。 早期発見のためのAI駆動の診断ツールへの投資。 脳震盪管理に関するスポーツ組織を対象とした教育プログラムの拡充。

2035年までに、脳震盪市場は堅調であり、重要な進展と市場の関与の増加を反映すると期待されています。

## Segment Insights

### 診断と治療による：診断（最大）対治療（最も成長している）

脳震盪市場では、診断セグメントが現在、市場シェアの重要な部分を占めており、脳震盪を特定するために使用される確立された手法と技術によるものです。臨床評価や高度な画像技術を含む診断方法は、脳震盪管理において不可欠なものとなっており、堅実な市場の存在に寄与しています。一方、治療セグメントは現在は小さいものの、革新的な治療法やリハビリテーション技術が登場し、脳震盪の長期的な影響に対処するために急速に注目を集めています。

診断：臨床評価（支配的）対治療：リハビリテーション技術（新興）

診断セグメント、特に臨床評価は、早期発見と介入における重要な役割のため、脳震盪市場で支配的な地位を維持しています。標準化されたプロトコルと高度な画像ツールは、これらの評価の効率を高め、正確な診断を確保します。一方、治療方法論、特にリハビリテーション技術は、新興段階にあり、脳震盪管理における長期的な重要性が高まっています。このセグメントは進化しており、個別化された治療計画や多職種アプローチの急増を示しており、脳震盪の影響に対する認識が高まる中で、ホリスティックケアへのシフトを示しています。

### エンドユーザーによる：病院とクリニック（最大）対診断センター（最も成長している）

脳震盪市場では、病院とクリニックが最大のシェアを持ち、確立されたインフラと包括的な患者ケア能力から利益を得ています。彼らは、高度な医療技術と幅広い専門家へのアクセスにより、脳震盪の診断と管理において重要な役割を果たしています。一方、診断センターは、脳震盪評価に特化したサービスを提供することで市場の足跡を拡大しており、迅速かつ正確な診断を求める患者を引き寄せています。成長の傾向は、脳震盪の影響に対する認識の高まりと、即時の評価と治療オプションの需要によって、診断センターの拡大に向けた重要なシフトを示しています。さらに、病院とクリニックは、革新的な技術や治療アプローチを取り入れることで進化しており、患者に対する魅力をさらに高めています。脳震盪の認識キャンペーンが増加し、スポーツ関連の頭部外傷への強調が高まる中、両セグメントは今後数年で顕著な成長が期待されています。

病院とクリニック（支配的）対診断センター（新興）

病院とクリニックは、脳震盪市場における支配的なセグメントを表しており、高度な画像技術や多職種チームを含む包括的な患者ケアアプローチが特徴です。彼らは、初期評価から継続的なリハビリテーションまで、幅広いサービスを提供し、脳震盪管理に対するホリスティックなアプローチを確保しています。診断センターは、新興ではあるものの、脳震盪診断のための集中サービスを提供することで急速に注目を集めています。彼らは、迅速な評価を必要とする患者のために合理化されたサービスを提供するニッチ市場に対応しています。早期発見と管理の重要性が認識される中、診断センターは現代の診断ツールを活用しており、医療の風景において有利な位置を占めています。

## Regional Market Share Analysis

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Concussions Market area will dominate this market, because to the continent's higher prevalence of concussions caused by car accidents and sports injuries, as well as increased government activities and awareness campaigns linked to concussion prevention, diagnosis, and treatment. According to the American Physical Therapy Association (APTA), around 8.6 million sports injuries are documented in this region each year.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Europe Concussions Market accounts for the second-largest market share due to rising awareness of the significance of concussions and their potential long-term consequences. Further, the German Concussions Market held the largest market share, and the UK Concussions Market was the fastest growing market in the European region

The Asia-Pacific Concussions Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to causes such as an older population that is more sensitive to falls, an increase in the number of road accidents, and violence. Moreover, China’s Concussions Market held the largest market share, and the Indian Concussions Market was the fastest growing market in the Asia-Pacific region.

## Competitive Benchmarking

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Concussions Market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Concussionsindustry must offer cost-effective items.
 
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  Concussions industry to benefit clients and increase the market sector. In recent years, the Concussions industry has offered some of the most significant advantages to medicine. Major players in the Concussions Market, including Advanced Brain Monitoring, Inc. BioDirection, Inc. BrainScope Company, Inc. InfraScan, Inc, and Nova Signal Corporation,  and others, are attempting to increase market demand by investing in research and development operations.
 
Acorda Therapeutics, Inc. is a biotechnology business headquartered in Pearl River, New York. The company creates medicines to help people with Parkinson's disease, multiple sclerosis, and other neurological illnesses improve their neurological function. In the United States, Acorda Therapeutics develops and markets the medications Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine).  In 2020, Acorda Therapeutics has formed a strategic alliance with the Medical University of South Carolina to develop and commercialize a new concussion therapy.
 
The collaboration planned to use Acorda's neuroscience expertise and the university's experience in concussion research to create new treatment choices for patients. Eli Lilly and corporation is a pharmaceutical corporation based in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in over 125 countries. Colonel Eli Lilly, a pharmaceutical chemist and American Civil War veteran, created and named the corporation in 1876. Colonel Eli Lilly, a pharmaceutical chemist and Union army veteran of the American Civil War, founded the corporation. 
 
Lilly was president of the corporation until his death in 1898. In 2020, Eli Lilly and business announced a collaboration with Imago BioSciences, a biotechnology business, to investigate a viable treatment for concussions. The collaboration planned to use Imago's small molecule inhibitor technology to target the immune system and reduce post-concussion inflammation.

## Recent News & Developments

In March 2026, Northwell Health's North Shore University Hospital, a Level I trauma center, began using Abbott's i-STAT Alinity TBI whole-blood test (measuring GFAP and UCH-L1 biomarkers) in its emergency department to assess suspected concussion/mild TBI in about 15 minutes. It's a real-world clinical adoption milestone (not just a regulatory clearance) showing Abbott's TBI diagnostic moving into high-volume ER settings, reinforcing its lead in the objective concussion-testing segment of the market. (Source: [northwell.edu](https://www.northwell.edu/news/the-latest/northwell-first-in-nys-to-use-traumatic-brain-injury-blood-test))

In December 2025, Medtronic announced U.S. clearance of a new indication for its Onyx Liquid Embolic System — middle meningeal artery embolization as an adjunct to surgery for symptomatic subacute/chronic subdural hematoma — based on the EMBOLISE trial (published in NEJM, Nov 2024), showing ~63% reduction in recurrence/re-operation when combined with surgery. cSDH is a traumatic brain injury commonly caused by head trauma/falls — adjacent to, but distinct from, "concussion" in the strict mTBI sense. I'm flagging this explicitly: it's real, dated, and TBI-related, but it is not a concussion-specific product, so treat it as adjacent-market context rather than a direct concussion-market development. (Source: [news.medtronic.com](https://news.medtronic.com/Medtronic-announces-new-treatment-option-for-chronic-subdural-hematoma-cSDH))

## Report Scope

| MARKET SIZE 2024 | 6.336(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 6.691(USD Billion) |
| MARKET SIZE 2035 | 11.54(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.6% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Abbott Laboratories (US), Medtronic (US), Boston Scientific (US), Stryker Corporation (US), Cortech Solutions (US), Zynex Medical (US), Neurotech Pharmaceuticals (US), Huntleigh Healthcare (GB), B. Braun Melsungen AG (DE) |
| Segments Covered | Diagnosis & Treatment, End-User, Region |
| Key Market Opportunities | Advancements in diagnostic technologies enhance early detection and treatment options in the Concussions Market. |
| Key Market Dynamics | Rising awareness of concussion risks drives demand for advanced diagnostic tools and treatment options in the healthcare sector. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: 2024年の脳震盪市場の現在の評価額はどれくらいですか？**
A: 脳震盪市場は2024年に63.36億米ドルと評価されました。

**Q: 2035年の脳震盪市場の予測市場規模はどれくらいですか？**
A: 市場は2035年までに115.4億米ドルに達すると予測されています。

**Q: 2025年から2035年の予測期間中の脳震盪市場の期待CAGRはどれくらいですか？**
A: 2025年から2035年の間の脳震盪市場の期待CAGRは5.6%です。

**Q: 脳震盪市場で分析されるセグメントはどれですか？**
A: 市場は診断と治療、そしてエンドユーザーによってセグメント化されています。

**Q: 2035年までの診断セグメントの予測値はどれくらいですか？**
A: 診断セグメントは2035年までに25億米ドルから45億米ドルに成長すると予測されています。

**Q: 2035年までに治療セグメントの評価額はどれくらいになると予想されていますか？**
A: 治療セグメントは2035年までに38.36億米ドルから70.4億米ドルに増加すると予想されています。

**Q: 脳震盪市場における病院とクリニックの期待される評価額はどれくらいですか？**
A: 病院とクリニックは2035年までに25億米ドルから45億米ドルに成長すると予測されています。

**Q: アボットラボラトリーズやメドトロニックなどの主要プレーヤーは市場でどのような役割を果たしていますか？**
A: アボットラボラトリーズやメドトロニックなどの主要プレーヤーは、革新と市場成長を促進する上で重要な役割を果たしています。

**Q: 脳震盪市場における診断センターの予測成長はどれくらいですか？**
A: 診断センターは2035年までに15億米ドルから25億米ドルに成長すると予想されています。

**Q: 支払者は脳震盪市場の成長にどのように貢献していますか？**
A: 支払者は2035年までに23.36億米ドルから45.4億米ドルに増加すると予測されており、その重要性が高まっています。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/concussions-market-5724*